Overview
Ehlers-Danlos syndromes are heritable connective-tissue disorders with varying combinations of joint hypermobility, tissue fragility, skin findings, pain, and other manifestations. Different subtypes have different risks.
What current evidence indicates
- Most EDS subtypes have identified genetic causes; hypermobile EDS currently has no established molecular test and is diagnosed using clinical criteria.
- Management is individualized: a clinician may focus first on protecting unstable joints and building tolerable strength through physical or occupational therapy, joint-stability work, braces or splints, pain management, and subtype-specific surveillance.
- A systematic review found possible benefits from exercise and rehabilitation, but studies were small and many had substantial risk of bias.
What remains uncertain
High-quality treatment trials are sparse, especially for hEDS. Evidence is insufficient for many commonly promoted procedures, supplements, and devices. Vascular or organ-fragility concerns require subtype-specific specialist care.
Useful details for a clinical visit
- Joint instability, dislocations, injuries, skin and wound history
- Family history and features that may indicate a genetic subtype
- Goals for safe function, rehabilitation, and symptom management
Primary and authoritative sources
This summary provides general education and cannot determine whether you have this condition or which treatment is appropriate. Discuss symptoms, testing, and treatment decisions with a qualified clinician.
← Return to research library